Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

Janne Kudsk Klitgaard; Claes Søndergaard Wassmann

Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

Bidragets oversatte titel: Bacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterielle infektioner

Janne Kudsk Klitgaard (Opfinder), Claes Søndergaard Wassmann (Opfinder)

Publikation: Patent

Abstrakt

The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.

Originalsprog	Engelsk
IPC	A61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04
Patentnummer	WO 2108/234301 A1
Journaliseringsdato	27/12/2018
Land	Danmark
Prioritetsdato	19/06/2017
Prioritetsnummer	EP20170176612
Status	Udgivet - 27. dec. 2018

Fingerprint

Citationsformater

Klitgaard, J. K., & Wassmann, C. S. (2018). IPC nr. A61K 31/352, A61K 45/06, A61K 38/12, A61P 31/04. Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections. (Patentnummer WO 2108/234301 A1).

@misc{91ab978ba6f44038b505d8176c3a3346,

title = "Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections",

abstract = "The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.",

author = "Klitgaard, {Janne Kudsk} and Wassmann, {Claes S{\o}ndergaard}",

year = "2018",

month = dec

day = "27",

language = "English",

type = "Patent",

note = "WO 2108/234301 A1; A61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04",

}

TY - PAT

T1 - Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

AU - Klitgaard, Janne Kudsk

AU - Wassmann, Claes Søndergaard

PY - 2018/12/27

Y1 - 2018/12/27

N2 - The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.

AB - The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.

UR - https://patentscope2.wipo.int/search/en/detail.jsf;jsessionid=FBC1DDFACED7ED5A8FC4816A8DBD7539?docId=WO2018234301&recNum=1874&office=&queryString=&prevFilter=%26fq%3DOF%3AWO&sortOption=Pub+Date+Desc&maxRec=3443385

M3 - Patent

M1 - WO 2108/234301 A1

Y2 - 2018/12/27

ER -

Dokumenter og links

https://patentscope2.wipo.int/search/en/detail.jsf;jsessionid=FBC1DDFACED7ED5A8FC4816A8DBD7539?docId=WO2018234301&recNum=1874&office=&queryString=&prevFilter=%26fq%3DOF%3AWO&sortOption=Pub+Date+Desc&maxRec=3443385